Restore3da North Carolina-based maker of personalized 3D-printed orthopedic implants has locked down $70 million in financing — whilst investors proceed to draw back from 3D startups.
The round includes a $55 million round. Summers Value Partners and existing investors plus an additional $15 million in debt financing led by Capital of the Trinity.
“This round of fundraising is a testament to the confidence investors have in Restor3D’s vision and potential,” said the CEO Kurt Jacobus. “With this capital, we can accelerate our efforts to transform orthopedic care with personalized 3D-printed implants.”
The startup operates at the unique intersection of healthcare/biotechnology, artificial intelligence and 3D technology. The company uses biomaterials, 3D printing technologies and artificial intelligence to assist repair the human body. It plans to introduce recent implant systems for total ankle and shoulder alternative, offering 3D printed solutions that adapt to the unique anatomy of individual patients.
Founded in 2017, the company has raised nearly $150 million, on Crunchbase.
3D funding is declining
Restor3D financing is an extremely large bet by investors in 3D Tech.
Although the sector made big money in 2021 and 2022, the sector has returned to a recent reality in the last two years.
While greater than $2.4 billion was invested in VC-backed industry startups in 2022, that number dropped to simply about $1 billion last yr, in keeping with Crunchbase data.
The situation is similar this yr, with only about $424 million raised so far.
Retor3d’s raise is the second largest in the industry this yr, second only to the increase Exodigo‘S Series A for $75 million in February. This startup offers subsurface image mapping solutions.